Tianjin Ringpu Bio Tech (300119) — Financial Flexibility Index
Tianjin Ringpu Bio Tech (300119) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥128.27 Million (operating CF CN¥105.02 Million minus capex CN¥23.24 Million) represents 0% of total liabilities (CN¥2.54 Billion). Also explore net asset momentum of Tianjin Ringpu Bio Tech to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Ringpu Bio Tech Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Tianjin Ringpu Bio Tech across 19 annual periods. Check Tianjin Ringpu Bio Tech (300119) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tianjin Ringpu Bio Tech (2007–2025)
Year-by-year free cash flow to debt coverage for Tianjin Ringpu Bio Tech. For the full company profile including market capitalisation, see 300119 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥473.64 Million | CN¥297.53 Million | CN¥2.47 Billion | ▼ -38.4% |
| 2024 | 0.31x | CN¥920.88 Million | CN¥735.55 Million | CN¥2.96 Billion | ▼ -10.5% |
| 2023 | 0.35x | CN¥622.68 Million | CN¥378.20 Million | CN¥1.79 Billion | ▼ -26.8% |
| 2022 | 0.47x | CN¥761.92 Million | CN¥389.49 Million | CN¥1.61 Billion | ▼ -5.7% |
| 2021 | 0.50x | CN¥688.50 Million | CN¥382.63 Million | CN¥1.37 Billion | ▼ -9.6% |
| 2020 | 0.56x | CN¥647.61 Million | CN¥388.44 Million | CN¥1.16 Billion | ▲ +9.6% |
| 2019 | 0.51x | CN¥613.31 Million | CN¥383.61 Million | CN¥1.21 Billion | ▲ +31.7% |
| 2018 | 0.39x | CN¥287.33 Million | CN¥174.88 Million | CN¥744.03 Million | ▲ +33.5% |
| 2017 | 0.29x | CN¥216.44 Million | CN¥107.57 Million | CN¥747.95 Million | ▼ -45.9% |
| 2016 | 0.53x | CN¥335.80 Million | CN¥207.67 Million | CN¥627.74 Million | ▼ -17.6% |
| 2015 | 0.65x | CN¥376.36 Million | CN¥225.27 Million | CN¥579.77 Million | ▼ -46.4% |
| 2014 | 1.21x | CN¥311.48 Million | CN¥128.37 Million | CN¥257.23 Million | ▲ +0.7% |
| 2013 | 1.20x | CN¥340.29 Million | CN¥88.68 Million | CN¥282.89 Million | ▼ -3.2% |
| 2012 | 1.24x | CN¥257.29 Million | CN¥89.92 Million | CN¥206.99 Million | ▼ -20.9% |
| 2011 | 1.57x | CN¥275.10 Million | CN¥90.29 Million | CN¥175.12 Million | ▲ +91.4% |
| 2010 | 0.82x | CN¥160.61 Million | CN¥112.82 Million | CN¥195.66 Million | ▲ +39.2% |
| 2009 | 0.59x | CN¥95.93 Million | CN¥64.59 Million | CN¥162.63 Million | ▼ -42.7% |
| 2008 | 1.03x | CN¥87.73 Million | CN¥68.07 Million | CN¥85.18 Million | ▲ +43.2% |
| 2007 | 0.72x | CN¥36.14 Million | CN¥19.15 Million | CN¥50.26 Million | — |